ReviewCancers2022
Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer.
Jiajun Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ReviewCancers2022
Jiajun Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.